Cargando…

17α-Hydroxyprogesterone Caproate Inhibits Cytokine Production via Suppression of NF-κB Activation

Cytokine release syndrome (CRS) is one of the leading causes of morbidity and mortality in COVID-19 patients with elevated levels of circulating cytokines contributing to various clinical symptoms. Favorable control of CRS represents a promising and effective strategy to mitigate the clinical outcom...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hu, Tao, Tang, Chengjifu, Stern, Sydney, Yang, Luan, Du, Tom
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8940231/ https://www.ncbi.nlm.nih.gov/pubmed/35330839 http://dx.doi.org/10.3389/fphar.2022.831315

Ejemplares similares

The Influence of Prior Obstetrical History on Current 17-Hydroxyprogesterone Caproate Use
por: Ransom, Carla E., et al.
Publicado: (2011)

Comparison of intravaginal progesterone gel and intramuscular 17-α-hydroxyprogesterone caproate in luteal phase support
por: SATIR, FUNDA, et al.
Publicado: (2013)

Functional effects of 17alpha-hydroxyprogesterone caproate (17P) on human myometrial contractility in vitro
por: Sexton, Donal J, et al.
Publicado: (2004)

In Utero Exposure to 17α-Hydroxyprogesterone Caproate May Contribute to Increasing Incidence Rates of Early-Onset Cancer
por: Murphy, Caitlin C, et al.
Publicado: (2021)

Quality investigation of hydroxyprogesterone caproate active pharmaceutical ingredient and injection
por: Chollet, John L., et al.
Publicado: (2012)

Pharmacokinetics of Hydroxyprogesterone Caproate and its Primary Metabolites during Pregnancy
por: Boggess, Kim A., et al.
Publicado: (2018)

Maternal Characteristics Influencing the Development of Gestational Diabetes in Obese Women Receiving 17-alpha-Hydroxyprogesterone Caproate
por: Egerman, Robert, et al.
Publicado: (2014)

Patient and Provider Perspectives on Acceptability, Access, and Adherence to 17-Alpha-Hydroxyprogesterone Caproate for Preterm Birth Prevention
por: Garcia, Stephanie M., et al.
Publicado: (2021)

Can 17 hydroxyprogesterone caproate (17P) decrease preterm deliveries in patients with a history of PMC or pPROM?
por: Cohen, Gal, et al.
Publicado: (2022)

Safety review of hydroxyprogesterone caproate in women with a history of spontaneous preterm birth
por: Sibai, Baha, et al.
Publicado: (2020)

Evaluation the effect of 17-alpha hydroxyprogesterone caproate on gestational diabetes mellitus in pregnant women at risk for preterm birth
por: Rouholamin, Safoura, et al.
Publicado: (2015)

SUN-255 The Synthetic Progestin, 17-alpha-hydroxyprogesterone Caproate, Used in Human Pregnancy Alters Prefrontal Cortical Development in Rats
por: Lolier, Melanie L, et al.
Publicado: (2020)

17-Hydroxyprogesterone Caproate for the Prevention of Recurrent Preterm Birth – A Systematic Review and Meta-analysis Taking into Account the PROLONG Trial
por: Kuon, Ruben-J., et al.
Publicado: (2021)

17-Hydroxyprogesterone caproate improves hypertension and renal endothelin-1 in response to sFlt-1 induced hypertension in pregnant rats
por: Amaral, Lorena M., et al.
Publicado: (2020)

17-Hydroxyprogesterone caproate to prolong pregnancy after preterm rupture of the membranes: early termination of a double-blind, randomized clinical trial
por: Combs, C Andrew, et al.
Publicado: (2011)

Intramuscular 17-hydroxyprogesterone caproate to prevent preterm birth among HIV-infected women in Zambia: study protocol of the IPOP randomized trial
por: Price, Joan T., et al.
Publicado: (2019)

Critical appraisal of the efficacy, safety, and patient acceptability of hydroxyprogesterone caproate injection to reduce the risk of preterm birth
por: Vidaeff, Alex C, et al.
Publicado: (2013)

Improving Uptake and Adherence to 17-Hydroxyprogesterone Caproate in Non-Hispanic Black Women: A Mixed Methods Study of Potential Interventions from the Patient Perspective
por: Wheeler, Sarahn M., et al.
Publicado: (2019)

Weekly 17 alpha-hydroxyprogesterone caproate to prevent preterm birth among women living with HIV: a randomised, double-blind, placebo-controlled trial
por: Price, Joan T, et al.
Publicado: (2021)

Development and usability of a new subcutaneous auto-injector device to administer hydroxyprogesterone caproate to reduce the risk of recurrent preterm birth
por: Travanty, Michael N, et al.
Publicado: (2018)

Comparison of oral Dydrogesterone and 17-α hydroxyprogesterone caprate in the prevention of preterm birth
por: Alizadeh, Fahimeh, et al.
Publicado: (2022)

17-alpha hydroxyprogesterone caproate for the prevention of recurrent preterm birth among singleton pregnant women with a prior history of preterm birth: a systematic review and meta-analysis of six randomized controlled trials
por: Baradwan, Saeed, et al.
Publicado: (2021)

Cimifugin Suppresses NF-κB Signaling to Prevent Osteoclastogenesis and Periprosthetic Osteolysis
por: Duan, Juan, et al.
Publicado: (2021)

Cortisol, progesterone, 17α-hydroxyprogesterone, and TSH responses in dogs injected with low-dose lipopolysaccharide
por: Corder-Ramos, Nicole L.B., et al.
Publicado: (2019)

Calebin A targets the HIF-1α/NF-κB pathway to suppress colorectal cancer cell migration
por: Brockmueller, Aranka, et al.
Publicado: (2023)

Anti-Rheumatic Properties of Gentiopicroside Are Associated With Suppression of ROS-NF-κB-NLRP3 Axis in Fibroblast-Like Synoviocytes and NF-κB Pathway in Adjuvant-Induced Arthritis
por: Wang, Meiling, et al.
Publicado: (2020)

An unusual cause of adrenal insufficiency with elevation of 17-hydroxyprogesterone: case report
por: Teti, Claudia, et al.
Publicado: (2023)

Dehydrocostus Lactone Suppresses Dextran Sulfate Sodium-Induced Colitis by Targeting the IKKα/β-NF-κB and Keap1-Nrf2 Signalling Pathways
por: Yuan, Yun, et al.
Publicado: (2022)

Measurement of Serum 17α-hydroxyprogesterone in Newborn Infants by Stable Isotope Dilution—Gas Chromatography/Mass Spectrometry
por: Homma, Keiko, et al.
Publicado: (2009)

First Morning Pregnanetriol and 17-Hydroxyprogesterone Correlated Significantly in 21-Hydroxylase Deficiency
por: Itonaga, Tomoyo, et al.
Publicado: (2022)

Gardenia Decoction Prevent Intestinal Mucosal Injury by Inhibiting Pro-inflammatory Cytokines and NF-κB Signaling
por: Cui, Yizhe, et al.
Publicado: (2019)

Large Screening Identifies ACE2 Positively Correlates With NF-κB Signaling Activity and Targeting NF-κB Signaling Drugs Suppress ACE2 Levels
por: Yan, Meichen, et al.
Publicado: (2021)

Protective Effect of Fluorofenidone Against Acute Lung Injury Through Suppressing the MAPK/NF-κB Pathway
por: Lv, Xin, et al.
Publicado: (2021)

Juglanin Inhibits Osteoclastogenesis in Ovariectomized Mice via the Suppression of NF-κB Signaling Pathways
por: Zhang, Fangxue, et al.
Publicado: (2021)

N-Acetyldopamine Dimer Attenuates DSS-Induced Ulcerative Colitis by Suppressing NF-κB and MAPK Pathways
por: Huang, Li-Jun, et al.
Publicado: (2022)

Comparing intramuscular progesterone, vaginal progesterone and 17 -hydroxyprogestrone caproate in IVF and ICSI cycle
por: Moini, Ashraf, et al.
Publicado: (2011)

Avenanthramide C Suppresses Matrix Metalloproteinase-9 Expression and Migration Through the MAPK/NF- κB Signaling Pathway in TNF-α-Activated HASMC Cells
por: Park, Junyoung, et al.
Publicado: (2021)

Chang qing formula ameliorates colitis-associated colorectal cancer via suppressing IL-17/NF-κB/STAT3 pathway in mice as revealed by network pharmacology study
por: Luo, Qihan, et al.
Publicado: (2022)

Anti-Osteoclast Effect of Exportin-1 Inhibitor Eltanexor on Osteoporosis Depends on Nuclear Accumulation of IκBα–NF-κB p65 Complex
por: Chen, Junchun, et al.
Publicado: (2022)

Sophocarpine Suppresses NF-κB-Mediated Inflammation Both In Vitro and In Vivo and Inhibits Diabetic Cardiomyopathy
por: Zou, Fang, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_cgbsd7tdjou4og7h49ao9l7v35